Procept BioRobotics Corporation

Procept BioRobotics Corporation focuses on developing and commercializing surgical robotics technology. The company's flagship product, AquaBeam Robotic System, is designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia, a condition commonly affecting older men. Utilizing advanced imaging, the robotic system provides a minimally invasive treatment option that improves patient outcomes by reducing recovery times and hospital stays. Procept BioRobotics serves a critical role in the medical device industry, emphasizing innovation in surgical solutions for urological health. As a pioneer in autonomous tissue resection, Procept BioRobotics aims to enhance the efficiency and safety of surgical procedures, making it an influential player in the field of medical robotics. Based in the healthcare sector, the company's technologies are increasingly significant as the demand for precision medicine and minimally invasive procedures grows. Procept BioRobotics is strategically positioned at the intersection of technological advancement and healthcare improvement, contributing to the ongoing evolution of medical treatment methodologies.